Assessment of blepharospasm surgery using an improved disability scale: Study of 138 patients

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 3, 2005, Pages 230-234

  Grivet, Damien ^a   Robert, Pierre Yves ^b   Thuret, Gilles ^a   De Féligonde, Olivier Pellissier ^c   Gain, Philippe ^a   Maugery, Jean ^a   Adenis, Jean Paul ^b  

^a SERVICE DE NEUROLOGIE   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ACCURACY; ADULT; AGED; APRAXIA; ARTICLE; BLEPHAROSPASM; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EYE SURGERY; EYELID; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBICULARIS OCULI MUSCLE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCORING SYSTEM; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OCULOMOTOR MUSCLES; RETROSPECTIVE STUDIES;

EID: 20544449054     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000162429.97307.4D     Document Type: Article

References (14)

1. Adenis JP, Smolik I. Blépharospasme. In: Adenis JP, Morax S. Pathologie orbito-palpébrale, Rapport de la Société Française d'Ophtalmologie. Paris: Masson; 1998:211-8.
2. Anderson RL, Patel BC, Holds JB, et al. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg 1998;14:305-17.
3. Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-50.
4. Elston JS. Botulinum toxin treatment of blepharospasm. Adv Neurol 1988;50:579-81.
5. Adenis JP. Treatment of blepharospasm: medical or surgical? Bull Soc Ophtalmol Fr 1987;12:1423-5.
6. Roggenkamper P, Nussgens Z. Frontalis suspension in the treatment of essential blepharospasm unresponsive to botulinum-toxin therapy: long-term results. Graefes Arch Clin Exp Ophthalmol 1997;235:486-9.
7. Nussgens Z, Roggenkamper P. Long-term treatment of blepharospasm with, botulinum toxin type A. Ger J Ophthalmol 1995;4: 363-7.
8. Jones TW Jr, Waller RR, Samples JR. Myectomy for essential blepharospasm. Mayo Clin Proc 1985;60:663-6.
9. Adenis JP, Elbelhadji M, Lasudry J. et al. Chirurgie du blépharospasme: Etude de 64 opérations. Ophtalmologie 1998;12:467-72.
10. Chapman KL, Bartley GB, Waller RR, et al. Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995. Ophthal Plast Reconstr Surg 1999;15:106-10.
11. Fahn S. Rating scales for blepharospasm. Adv Ophthal Plast Reconstr Surg 1985;4:97-101.
12. Lindenboom R, De Haan R, Aramideh M, et al. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 1995;10:444-9.
13. Anderson RL, Patrinely JR. Surgical management of blepharospasm. Adv Neurol 1988;49:501-20.
14. De Groot V, De Wilde F, Smet L, et al. Frontalis suspension combined with blepharoplasty as an effective treatment for blepharospasm associated with apraxia of eyelid opening. Ophthal Plast Reconstr Surg 2000;16:34-8.